The Papillomavirus E2 proteins

Virology

Volumn 445, Issue 1-2, 2013, Pages 57-79

  McBride, Alison A ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

E2; Genomics; HPV; Mutation; Papillomavirus; Replication; Structure; Tethering; Transcription

Indexed keywords

VIRUS PROTEIN;

ARTICLE; BINDING SITE; CONTROLLED STUDY; DNA PACKAGING; DNA REPLICATION; LIFE CYCLE; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; TRANSCRIPTION REGULATION; VIRUS GENOME;

E2; GENOMICS; HPV; MUTATION; PAPILLOMAVIRUS; REPLICATION; STRUCTURE; TETHERING; TRANSCRIPTION;

ANIMALS; BASE SEQUENCE; BINDING SITES; DNA-BINDING PROTEINS; GENOME, VIRAL; MUTATION; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STABILITY; PROTEIN STRUCTURE, TERTIARY; TRANSCRIPTIONAL ACTIVATION; VIRUS ASSEMBLY; VIRUS REPLICATION;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

EID: 84884354648     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.06.006     Document Type: Article

References (291)

1. Abbate E.A., Berger J.M., Botchan M.R. The X-ray structure of the papillomavirus helicase in complex with its molecular matchmaker E2. Genes Dev. 2004, 18:1981-1996.
2. Abbate E.A., Voitenleitner C., Botchan M.R. Structure of the papillomavirus DNA-tethering complex E2:Brd4 and a peptide that ablates HPV chromosomal association. Mol. Cell 2006, 24:877-889.
3. Abroi A., Ilves I., Kivi S., Ustav M. Analysis of chromatin attachment and partitioning functions of bovine papillomavirus type 1 E2 protein. J. Virol. 2004, 78:2100-2113.
4. Abroi A., Kurg R., Ustav M. Transcriptional and replicational activation functions in the BPV1 E2 protein are encoded by different structural determinants. J. Virol. 1996, 70:6169-6179.
5. Akgul B., Pfefferle R., Marcuzzi G.P., Zigrino P., Krieg T., Pfister H., Mauch C. Expression of matrix metalloproteinase (MMP)-2, MMP-9, MMP-13, and MT1-MMP in skin tumors of human papillomavirus type 8 transgenic mice. Exp. Dermatol. 2006, 15:35-42.
6. Alderborn A., Jareborg N., Burnett S. Evidence that the transcriptional trans-activating function of the bovine papillomavirus type 1 E2 gene is not required for viral DNA amplification in division-arrested cells. J. Gen. Virol. 1992, 73:2639-2651.
7. Ammermann I., Bruckner M., Matthes F., Iftner T., Stubenrauch F. Inhibition of transcription and DNA replication by the papillomavirus E8-E2C protein is mediated by interaction with corepressor molecules. J. Virol. 2008, 82:5127-5136.
8. Androphy E.J., Lowy D.R., Schiller J.T. Bovine papillomavirus E2 trans-activating gene product binds to specific sites in papillomavirus DNA. Nature 1987, 325:70-73.
9. Antson A.A., Burns J.E., Moroz O.V., Scott D.J., Sanders C.M., Bronstein I.B., Dodson G.G., Wilson K.S., Maitland N.J. Structure of the intact transactivation domain of the human papillomavirus E2 protein. Nature 2000, 403:805-809.
10. Auster A.S., Joshua-Tor L. The DNA-binding domain of human papillomavirus type 18 E1. Crystal structure, dimerization, and DNA binding. J. Biol. Chem. 2004, 279:3733-3742.
11. Baker C.C., Phelps W.C., Lindgren V., Braun M.J., Gonda M.A., Howley P.M. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J. Virol. 1987, 61:962-971.
12. Barbosa M.S., Wettstein F.O. E2 of cottontail rabbit papillomavirus is a nuclear phosphoprotein translated from an mRNA encoding multiple open reading frames. J. Virol. 1988, 62:3242-3249.
13. Barsoum J., Prakash S.S., Han P., Androphy E.J. Mechanism of action of the papillomavirus E2 repressor: repression in the absence of DNA binding. J. Virol. 1992, 66:3941-3945.
14. Bastien N., McBride A.A. Interaction of the papillomavirus E2 protein with mitotic chromosomes. Virology 2000, 270:124-134.
15. Baxter M.K., McBride A.A. An acidic amphipathic helix in the Bovine Papillomavirus E2 protein is critical for DNA replication and interaction with the E1 protein. Virology 2005, 332:78-88.
16. Baxter M.K., McPhillips M.G., Ozato K., McBride A.A. The mitotic chromosome binding activity of the papillomavirus E2 protein correlates with interaction with the cellular chromosomal protein, Brd4. J. Virol. 2005, 79:4806-4818.
17. Behren A., Simon C., Schwab R.M., Loetzsch E., Brodbeck S., Huber E., Stubenrauch F., Zenner H.P., Iftner T. Papillomavirus E2 protein induces expression of the matrix metalloproteinase-9 via the extracellular signal-regulated kinase/activator protein-1 signaling pathway. Cancer Res. 2005, 65:11613-11621.
18. Bellanger S., Demeret C., Goyat S., Thierry F. Stability of the human papillomavirus type 18 E2 protein is regulated by a proteasome degradation pathway through its amino-terminal transactivation domain. J. Virol. 2001, 75:7244-7251.
19. Bellanger S., Blachon S., Mechali F., Bonne-Andrea C., Thierry F. High-risk but not low-risk HPV E2 proteins bind to the APC activators Cdh1 and Cdc20 and cause genomic instability. Cell Cycle 2005, 4:1608-1615.
20. Bellanger S., Tan C.L., Nei W., He P.P., Thierry F. The human papillomavirus type 18 E2 protein is a cell cycle-dependent target of the SCFSkp2 ubiquitin ligase. J. Virol. 2010, 84:437-444.
21. Bellanger S., Tan C.L., Xue Y.Z., Teissier S., Thierry F. Tumor suppressor or oncogene? A critical role of the human papillomavirus (HPV) E2 protein in cervical cancer progression. Am. J. Cancer Res. 2011, 1:373-389.
22. Bermudez-Morales V.H., Peralta-Zaragoza O., Alcocer-Gonzalez J.M., Moreno J., Madrid-Marina V. IL-10 expression is regulated by HPV E2 protein in cervical cancer cells. Mol. Med. Rep. 2011, 4:369-375.
23. Bernard B.A., Bailly C., Lenoir M.C., Darmon M., Thierry F., Yaniv M. The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes. J. Virol. 1989, 63:4317-4324.
24. Bian X.L., Wilson V.G. Common importin alpha specificity for papillomavirus E2 proteins. Virus Res. 2010, 150:135-137.
25. Blachon S., Bellanger S., Demeret C., Thierry F. Nucleo-cytoplasmic shuttling of high risk human Papillomavirus E2 proteins induces apoptosis. J. Biol. Chem. 2005, 280:36088-36098.
26. Bochkarev A., Barwell J.A., Pfuetzner R.A., Furey W., Edwards A.M., Frappier L. Crystal structure of the DNA-binding domain of the Epstein-Barr virus origin-binding protein EBNA 1. Cell 1995, 83:39-46.
27. Bodaghi S., Jia R., Zheng Z.M. Human papillomavirus type 16 E2 and E6 are RNA-binding proteins and inhibit in vitro splicing of pre-mRNAs with suboptimal splice sites. Virology 2009, 386:32-43.
28. Boner W., Taylor E.R., Tsirimonaki E., Yamane K., Campo M.S., Morgan I.M. A Functional interaction between the human papillomavirus 16 transcription/replication factor E2 and the DNA damage response protein TopBP1. J. Biol. Chem. 2002, 277:22297-22303.
29. Bouvard V., Storey A., Pim D., Banks L. Characterization of the human papillomavirus E2 protein: evidence of trans-activation and trans-repression in cervical keratinocytes. EMBO J. 1994, 13:5451-5459.
30. Breiding D.E., Grossel M.J., Androphy E.J. Genetic analysis of the bovine papillomavirus E2 transcriptional activation domain. Virology 1996, 221:34-43.
31. Breiding D.E., Sverdrup F., Grossel M.J., Moscufo N., Boonchai W., Androphy E.J. Functional interaction of a novel cellular protein with the papillomavirus E2 transactivation domain. Mol. Cell. Biol. 1997, 17:7208-7219.
32. Brokaw J.L., Blanco M., McBride A.A. Amino acids critical for the functions of the bovine papillomavirus type 1 E2 transactivator. J. Virol. 1996, 70:23-29.
33. Brown C., Kowalczyk A.M., Taylor E.R., Morgan I.M., Gaston K. p53 represses human papillomavirus type 16 DNA replication via the viral E2 protein. Virol. J. 2008, 5:5.
34. Burnett S., Strom A.C., Jareborg N., Alderborn A., Dillner J., Moreno L.J., Pettersson U., Kiessling U. Induction of bovine papillomavirus E2 gene expression and early region transcription by cell growth arrest: correlation with viral DNA amplification and evidence for differential promoter induction. J. Virol. 1990, 64:5529-5541.
35. Burns J.E., Walker H.F., Schmitz C., Maitland N.J. Phenotypic effects of HPV-16 E2 protein expression in human keratinocytes. Virology 2010, 401:314-321.
36. Bussiere D.E., Kong X., Egan D.A., Walter K., Holzman T.F., Lindh F., Robins T., Giranda V.L. Structure of the E2 DNA-binding domain from human papillomavirus serotype 31 at 2.4 A. Acta Crystallogr., Section D, Biol. Crystallogr. 1998, 54:1367-1376.
37. Carrillo E., Garrido E., Gariglio P. Specific in vitro interaction between papillomavirus E2 proteins and TBP-associated factors. Intervirology 2004, 47:342-349.
38. Carruth, M., McBride, A.A., 2001. (unpublished data).
39. Centeno F., Ramirez-Salazar E., Garcia-Villa E., Gariglio P., Garrido E. TAF1 interacts with and modulates human papillomavirus 16 E2-dependent transcriptional regulation. Intervirology 2008, 51:137-143.
40. Cha S., Seo T. hSNF5 is required for human papillomavirus E2-driven transcriptional activation and DNA replication. Intervirology 2011, 54:66-77.
41. Chaiwongkot A., Vinokurova S., Pientong C., Ekalaksananan T., Kongyingyoes B., Kleebkaow P., Chumworathayi B., Patarapadungkit N., Reuschenbach M., von Knebel Doeberitz M. Differential methylation of E2 binding sites in episomal and integrated HPV 16 genomes in preinvasive and invasive cervical lesions. Int. J. Cancer 2013, 132:2087-2094.
42. Chang S.W., Tsao Y.P., Lin C.Y., Chen S.L. NRIP, a novel calmodulin binding protein, activates calcineurin to dephosphorylate human papillomavirus E2 protein. J. Virol. 2011, 85:6750-6763.
43. Chang S.W., Lu P.Y., Guo J.H., Tsai T.C., Tsao Y.P., Chen S.L. NRIP enhances HPV gene expression via interaction with either GR or E2. Virology 2012, 423:38-48.
44. Chatterjee R., Vinson C. CpG methylation recruits sequence specific transcription factors essential for tissue specific gene expression. Biochim. Biophys. Acta 2012, 1819:763-770.
45. Chen G., Stenlund A. Characterization of the DNA-binding domain of the bovine papillomavirus replication initiator E1. J. Virol. 1998, 72:2567-2576.
46. Chen G., Stenlund A. Two patches of amino acids on the E2 DNA binding domain define the surface for interaction with E1. J. Virol. 2000, 74:1506-1512.
47. ∧E2C fusion protein encoded by human papillomavirus type 11 is a sequence-specific transcription repressor. J. Virol. 1991, 65:3317-3329.
48. Chin M.T., Hirochika R., Hirochika H., Broker T.R., Chow L.T. Regulation of human papillomavirus type 11 enhancer and E6 promoter by activating and repressing proteins from the E2 open reading frame: functional and biochemical studies. J. Virol. 1988, 62:2994-3002.
49. Choe J., Vaillancourt P., Stenlund A., Botchan M. Bovine papillomavirus type 1 encodes two forms of a transcriptional repressor: structural and functional analysis of new viral cDNAs. J. Virol. 1989, 63:1743-1755.
50. Clower R.V., Hu Y., Melendy T. Papillomavirus E2 protein interacts with and stimulates human topoisomerase I. Virology 2006, 348:13-18.
51. Conway M.J., Alam S., Ryndock E.J., Cruz L., Christensen N.D., Roden R.B., Meyers C. Tissue-spanning redox gradient-dependent assembly of native human papillomavirus type 16 virions. J. Virol. 2009, 83:10515-10526.
52. Cooper C.S., Upmeyer S.N., Winokur P.L. Identification of single amino acids in the human papillomavirus 11 E2 protein critical for the transactivation or replication functions. Virology 1998, 241:312-322.
53. Corina K., Grossman S.R., Barsoum J., Prakash S.S., Androphy E.J., Pepinsky R.B. The tryptophan bridge is a critical feature of the papillomavirus E2 DNA binding domain. Virology 1993, 391-396.
54. Cripe T.P., Haugen T.H., Turk J.P., Tabatabai F., Schmid P.G.d., Dürst M., Gissmann L., Roman A., Turek L.P. Transcriptional regulation of the human papillomavirus- 16 E6-E7 promoter by a keratinocyte-dependent enhancer, and by viral E2 trans-activator and repressor gene products: implications for cervical carcinogenesis. EMBO J. 1987, 6:3745-3753.
55. Crooks G.E., Hon G., Chandonia J.M., Brenner S.E. WebLogo: a sequence logo generator. Genome Res. 2004, 14:1188-1190.
56. Dao L.D., Duffy A., Van Tine B.A., Wu S.Y., Chiang C.M., Broker T.R., Chow L.T. Dynamic localization of the human papillomavirus type 11 origin binding protein E2 through mitosis while in association with the spindle apparatus. J. Virol. 2006, 80:4792-4800.
57. Davy C., McIntosh P., Jackson D.J., Sorathia R., Miell M., Wang Q., Khan J., Soneji Y., Doorbar J. A novel interaction between the human papillomavirus type 16 E2 and E1--E4 proteins leads to stabilization of E2. Virology 2009, 394:266-275.
58. Day P.M., Baker C.C., Lowy D.R., Schiller J.T. Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression. Proc. Nat. Acad. Sci. USA 2004, 101:14252-14257.
59. Day P.M., Roden R.B., Lowy D.R., Schiller J.T. The papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein, E2, to PML oncogenic domains. J. Virol. 1998, 72:142-150.
60. Demeret C., Garcia-Carranca A., Thierry F. Transcription-independent triggering of the extrinsic pathway of apoptosis by human papillomavirus 18 E2 protein. Oncogene 2003, 22:168-175.
61. Desaintes C., Demeret C., Goyat S., Yaniv M., Thierry F. Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis. EMBO J. 1997, 16:504-514.
62. Deyrieux A.F., Rosas-Acosta G., Ozbun M.A., Wilson V.G. Sumoylation dynamics during keratinocyte differentiation. J. Cell Sci. 2007, 120:125-136.
63. DiMaio D., Settleman J. Bovine papillomavirus mutant temperature sensitive for transformation, replication and transactivation. EMBO J. 1988, 7:1197-1204.
64. Donaldson M.M., Boner W., Morgan I.M. TopBP1 regulates human papillomavirus type 16 E2 interaction with chromatin. J. Virol. 2007, 81:4338-4342.
65. Dong G., Broker T.R., Chow L.T. Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements. J. Virol. 1994, 68:1115-1127.
66. Dostatni N., Lambert P., Sousa R., Ham J., Howley P., Yaniv M. The functional BPV-1 E2 transactivating protein can act as a repressor by preventing formation of the initiation complex. Genes Dev. 1991.
67. Dostatni N., Thierry F., Yaniv M. A dimer of BPV-1 E2 containing a protease resistant core interacts with its DNA target. EMBO J. 1988, 7:3807-3816.
68. Dowhanick J.J., McBride A.A., Howley P.M. Suppression of cellular proliferation by the papillomavirus E2 protein. J. Virol. 1995, 69:7791-7799.
69. Enzenauer C., Mengus G., Lavigne A., Davidson I., Pfister H., May M. Interaction of human papillomavirus 8 regulatory proteins E2, E6 and E7 with components of the TFIID complex. Intervirology 1998, 41:80-90.
70. Ferguson M.F., Botchan M.R. Genetic analysis of the activation domain of bovine papillomavirus protein E2:its role in transcription and replication. J. Virol. 1996, 70:4193-4199.
71. Fertey J., Ammermann I., Winkler M., Stoger R., Iftner T., Stubenrauch F. Interaction of the papillomavirus E8--E2C protein with the cellular CHD6 protein contributes to transcriptional repression. J. Virol. 2010, 84:9505-9515.
72. Flores E.R., Lambert P.F. Evidence for a switch in the mode of human papillomavirus type 16 DNA replication during the viral life cycle. J. Virol. 1997, 71:7167-7179.
73. Fradet-Turcotte A., Bergeron-Labrecque F., Moody C.A., Lehoux M., Laimins L.A., Archambault J. Nuclear accumulation of the papillomavirus E1 helicase blocks S-phase progression and triggers an ATM-dependent DNA damage response. J. Virol. 2011, 85:8996-9012.
74. Frattini M.G., Laimins L.A. Binding of the human papillomavirus E1 origin-recognition protein is regulated through complex formation with the E2 enhancer-binding protein. PNAS Temp. 1994, 91:12398-12402.
75. Fujii T., Brandsma J.L., Peng X., Srimatkandada S., Li L., Canaan A., Deisseroth A.B. High and low levels of cottontail rabbit papillomavirus E2 protein generate opposite effects on gene expression. J. Biol. Chem. 2001, 276:867-874.
76. Gagnon D., Joubert S., Senechal H., Fradet-Turcotte A., Torre S., Archambault J. Proteasomal degradation of the papillomavirus E2 protein is inhibited by overexpression of bromodomain-containing protein 4. J. Virol. 2009, 83:4127-4139.
77. Gagnon D., Senechal H., D'Abramo C.M., Alvarez J., McBride A.A., Archambault J. Genetic analysis of the E2 transactivation domain dimerization interface from bovine papillomavirus type 1. Virology 2013, 439:132-139.
78. Gammoh N., Grm H.S., Massimi P., Banks L. Regulation of human papillomavirus type 16 E7 activity through direct protein interaction with the E2 transcriptional activator. J. Virol. 2006, 80:1787-1797.
79. Gammoh N., Gardiol D., Massimi P., Banks L. The Mdm2 ubiquitin ligase enhances transcriptional activity of human papillomavirus E2. J. Virol. 2009, 83:1538-1543.
80. Garcia-Alai M.M., Gallo M., Salame M., Wetzler D.E., McBride A.A., Paci M., Cicero D.O., de Prat-Gay G. Molecular basis for phosphorylation-dependent, PEST-mediated protein turnover. Structure 2006, 14:309-319.
81. Gasparian A.V., Fedorova M.D., Kisselev F.L. Regulation of matrix metalloproteinase-9 transcription in squamous cell carcinoma of uterine cervix: the role of human papillomavirus gene E2 expression and activation of transcription factor NF-kappaB. Biochem. Biokhimiia 2007, 72:848-853.
82. Gauthier J.M., Dillner J., Yaniv M. Structural analysis of the human papillomavirus type 16-E2 transactivator with antipeptide antibodies reveals a high mobility region linking the transactivation and the DNA-binding domains. Nucl. Acids Res. 1991, 19:7073-7079.
83. Gillespie K.A., Mehta K.P., Laimins L.A., Moody C.A. Human papillomaviruses recruit cellular DNA repair and homologous recombination factors to viral replication centers. J. Virol. 2012, 86:9520-9526.
84. Gillitzer E., Chen G., Stenlund A. Separate domains in E1 and E2 proteins serve architectural and productive roles for cooperative DNA binding. EMBO J. 2000, 19:3069-3079.
85. Giri I., Yaniv M. Structural and mutational analysis of E2 trans-activating proteins of papillomaviruses reveals three distinct functional domains. EMBO J. 1988, 7:2823-2829.
86. Goodwin E.C., DiMaio D. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. Proc. Nat. Acad. Sci. USA 2000, 97:12513-12518.
87. Goodwin E.C., Naeger L.K., Breiding D.E., Androphy E.J., DiMaio D. Transactivation-competent bovine papillomavirus E2 protein is specifically required for efficient repression of human papillomavirus oncogene expression and for acute growth inhibition of cervical carcinoma cell lines. J. Virol. 1998, 72:3925-3934.
88. Goodwin E.C., Yang E., Lee C.J., Lee H.W., DiMaio D., Hwang E.S. Rapid induction of senescence in human cervical carcinoma cells. Proc. Nat. Acad. Sci. USA 2000, 97:10978-10983.
89. Grm H.S., Massimi P., Gammoh N., Banks L. Crosstalk between the human papillomavirus E2 transcriptional activator and the E6 oncoprotein. Oncogene 2005, 24:5149-5164.
90. Grossel M.J., Barsoum J., Prakash S.S., Androphy E.J. The BPV-1 E2 DNA-contact helix cysteine is required for transcriptional activation but not replication in mammalian cells. Virology 1996, 217:301-310.
91. Grundhoff A., Ganem D. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus permits replication of terminal repeat-containing plasmids. J. Virol. 2003, 77:2779-2783.
92. Hadaschik D., Hinterkeuser K., Oldak M., Pfister H.J., Smola-Hess S. The Papillomavirus E2 protein binds to and synergizes with C/EBP factors involved in keratinocyte differentiation. J. Virol. 2003, 77:5253-5265.
93. Harris S.F., Botchan M.R. Crystal structure of the human papillomavirus type 18 E2 activation domain. Science 1999, 284:1673-1677.
94. Hartley K.A., Alexander K.A. Human TATA binding protein inhibits human papillomavirus type 11 DNA replication by antagonizing E1-E2 protein complex formation on the viral origin of replication. J. Virol. 2002, 76:5014-5023.
95. Hawley-Nelson P., Androphy E.J., Lowy D.R., Schiller J.T. The specific DNA recognition sequence of the bovine papillomavirus E2 protein is an E2-dependent enhancer. EMBO J. 1988, 7:525-531.
96. Hegde R.S. The papillomavirus E2 proteins: structure, function, and biology. Annu. Rev. Biophys. Biomol. Struct. 2002, 31:343-360.
97. Hegde R.S., Androphy E.J. Crystal structure of the E2 DNA-binding domain from human papillomavirus type 16: implications for its DNA binding-site selection mechanism. J. Mol. Biol. 1998, 284:1479-1489.
98. Hegde R.S., Grossman S.R., Laimins L.A., Sigler P.B. Crystal structure at 1.7 A of the bovine papillomavirus-1 E2 DNA- binding domain bound to its DNA target. Nature 1992, 359:505-512.
99. Hegde R.S., Wang A.F., Kim S.S., Schapira M. Subunit rearrangement accompanies sequence-specific DNA binding by the bovine papillomavirus-1 E2 protein. J. Mol. Biol. 1998, 276:797-808.
100. Heino P., Zhou J., Lambert P.F. Interaction of the papillomavirus Transcription/Replication factor, E2, and the viral capsid protein, L2. Virology 2000, 276:304-314.
101. Hernandez-Ramon E.E., Burns J.E., Zhang W., Walker H.F., Allen S., Antson A.A., Maitland N.J. Dimerization of the human papillomavirus type 16 E2 N terminus results in DNA looping within the upstream regulatory region. J. Virol. 2008, 82:4853-4861.
102. Hibma M.H., Raj K., Ely S.J., Stanley M., Crawford L. The interaction between human papillomavirus type 16 E1 and E2 proteins is blocked by an antibody to the N-terminal region of E2. Eur. J. Biochem. 1995, 229:517-525.
103. Hooley E., Fairweather V., Clarke A.R., Gaston K., Brady R.L. The recognition of local DNA conformation by the human papillomavirus type 6 E2 protein. Nucl. Acids Res. 2006, 34:3897-3908.
104. Hou S.Y., Wu S.Y., Zhou T., Thomas M.C., Chiang C.M. Alleviation of human papillomavirus E2-mediated transcriptional repression via formation of a TATA binding protein (or TFIID)-TFIIB-RNA polymerase II-TFIIF preinitiation complex. Mol. Cell. Biol. 2000, 20:113-125.
105. Hubbert N.L., Schiller J.T., Lowy D.R., Androphy E.J. Bovine papilloma virus-transformed cells contain multiple E2 proteins. Proc. Nat. Acad. Sci. USA 1988, 85:5864-5868.
106. Hwang E.S., Riese D.J.d., Settleman J., Nilson L.A., Honig J., Flynn S., DiMaio D. Inhibition of cervical carcinoma cell line proliferation by the introduction of a bovine papillomavirus regulatory gene. J. Virol. 1993, 67:3720-3729.
107. Ilves I., Kivi S., Ustav M. Long-term episomal maintenance of bovine papillomavirus type 1 plasmids is determined by attachment to host chromosomes, which Is mediated by the viral E2 protein and its binding sites. J. Virol. 1999, 73:4404-4412.
108. Ilves I., Maemets K., Silla T., Janikson K., Ustav M. Brd4 is involved in multiple processes of the bovine papillomavirus type 1 life cycle. J. Virol. 2006, 80:3660-3665.
109. Jackson M.E., Campo M.S. Both viral E2 protein and the cellular factor PEBP2 regulate transcription via E2 consensus sites within the bovine papillomavirus type 4 long control region. J. Virol. 1995, 69:6038-6046.
110. Jang M.K., Kwon D., McBride A.A. Papillomavirus E2 proteins and the host BRD4 protein associate with transcriptionally active cellular chromatin. J. Virol. 2009, 83:2592-2600.
111. Jang, M.K., McBride, A.A., 2013. (unpublished data).
112. Jeckel S., Huber E., Stubenrauch F., Iftner T. A transactivator function of cottontail rabbit papillomavirus e2 is essential for tumor induction in rabbits. J. Virol. 2002, 76:11209-11215.
113. Jeckel S., Loetzsch E., Huber E., Stubenrauch F., Iftner T. Identification of the E9/E2C cDNA and functional characterization of the gene product reveal a new repressor of transcription and replication in cottontail rabbit papillomavirus. J. Virol. 2003, 77:8736-8744.
114. Johansson C., Graham S.V., Dornan E.S., Morgan I.M. The human papillomavirus 16 E2 protein is stabilised in S phase. Virology 2009, 394:194-199.
115. Johansson C., Schwartz S. Regulation of human papillomavirus gene expression by splicing and polyadenylation. Nat. Rev. Microbiol. 2013, 11:239-251.
116. Johansson C., Somberg M., Li X., Backstrom Winquist E., Fay J., Ryan F., Pim D., Banks L., Schwartz S. HPV-16 E2 contributes to induction of HPV-16 late gene expression by inhibiting early polyadenylation. EMBO J. 2012, 31:3212-3227.
117. Johung K., Goodwin E.C., DiMaio D. Human papillomavirus E7 repression in cervical carcinoma cells initiates a transcriptional cascade driven by the retinoblastoma family, resulting in senescence. J. Virol. 2007, 81:2102-2116.
118. Kalantari M., Calleja-Macias I.E., Tewari D., Hagmar B., Lie K., Barrera-Saldana H.A., Wiley D.J., Bernard H.U. Conserved methylation patterns of human papillomavirus type 16 DNA in asymptomatic infection and cervical neoplasia. J. Virol. 2004, 78:12762-12772.
119. Kalantari M., Lee D., Calleja-Macias I.E., Lambert P.F., Bernard H.U. Effects of cellular differentiation, chromosomal integration and 5-aza-2'-deoxycytidine treatment on human papillomavirus-16 DNA methylation in cultured cell lines. Virology 2008, 374:292-303.
120. Kim K., Garner-Hamrick P.A., Fisher C., Lee D., Lambert P.F. Methylation patterns of papillomavirus DNA, its influence on E2 function, and implications in viral infection. J. Virol. 2003, 77:12450-12459.
121. Kim S.S., Tam J.K., Wang A.F., Hegde R.S. The structural basis of DNA target discrimination by papillomavirus E2 proteins. J. Biol. Chem. 2000, 275:31245-31254.
122. King L.E., Dornan E.S., Donaldson M.M., Morgan I.M. Human papillomavirus 16 E2 stability and transcriptional activation is enhanced by E1 via a direct protein-protein interaction. Virology 2011, 414:26-33.
123. Klucevsek K., Wertz M., Lucchi J., Leszczynski A., Moroianu J. Characterization of the nuclear localization signal of high risk HPV16 E2 protein. Virology 2007, 360:191-198.
124. Knight J.D., Li R., Botchan M. The activation domain of the bovine papillomavirus E2 protein mediates association of DNA-bound dimers to form DNA loops. Proc. Nat. Acad. Sci. USA 1991, 88:3204-3208.
125. Korkina L., Pastore S. The role of redox regulation in the normal physiology and inflammatory diseases of skin. Front. Biosci. (Elite edition) 2009, 1:123.
126. Kruppel U., Muller-Schiffmann A., Baldus S.E., Smola-Hess S., Steger G. E2 and the co-activator p300 can cooperate in activation of the human papillomavirus type 16 early promoter. Virology 2008, 377:151-159.
127. Kumar R.A., Naidu S.R., Wang X., Imbalzano A.N., Androphy E.J. Interaction of papillomavirus E2 protein with the Brm chromatin remodeling complex leads to enhanced transcriptional activation. J. Virol. 2007, 81:2213-2220.
128. Kurg R., Sild K., Ilves A., Sepp M., Ustav M. Association of bovine papillomavirus E2 protein with nuclear structures in vivo. J. Virol. 2005, 79:10528-10539.
129. Kurg R., Tekkel H., Abroi A., Ustav M. Characterization of the functional activities of the bovine papillomavirus type 1 E2 protein single-chain heterodimers. J. Virol. 2006, 80:11218-11225.
130. Kurg R., Uusen P., Sepp T., Sepp M., Abroi A., Ustav M. Bovine papillomavirus type 1 E2 protein heterodimer is functional in papillomavirus DNA replication in vivo. Virology 2009, 386:353-359.
131. Kurg R., Uusen P., Vosa L., Ustav M. Human papillomavirus E2 protein with single activation domain initiates HPV18 genome replication, but is not sufficient for long-term maintenance of virus genome. Virology 2010, 408:159-166.
132. Lace M.J., Anson J.R., Thomas G.S., Turek L.P., Haugen T.H. The E8--E2 gene product of human papillomavirus type 16 represses early transcription and replication but is dispensable for viral plasmid persistence in keratinocytes. J. Virol. 2008, 82:10841-10853.
133. Lai M.C., Teh B.H., Tarn W.Y. A human papillomavirus E2 transcriptional activator. The interactions with cellular splicing factors and potential function in pre-mRNA processing. J. Biol. Chem. 1999, 274:11832-11841.
134. Lambert P.F., Hubbert N.L., Howley P.M., Schiller J.T. Genetic assignment of multiple E2 gene products in bovine papillomavirus-transformed cells. J. Virol. 1989, 63:3151-3154.
135. Lambert P.F., Monk B.C., Howley P.M. Phenotypic analysis of bovine papillomavirus type 1 E2 repressor mutants. J. Virol. 1990, 64:950-956.
136. Lambert P.F., Spalholz B.A., Howley P.M. A transcriptional repressor encoded by BPV-1 shares a common carboxy-terminal domain with the E2 transactivator. Cell 1987, 50:69-78.
137. Lee A.Y., Chiang C.M. Chromatin adaptor Brd4 modulates E2 transcription activity and protein stability. J. Biol. Chem. 2009, 284:2778-2786.
138. Lee D., Hwang S.G., Kim J., Choe J. Functional interaction between p/CAF and human papillomavirus E2 protein. J. Biol. Chem. 2002, 277:6483-6489.
139. Lee D., Kim H.Z., Jeong K.W., Shim Y.S., Horikawa I., Barrett J.C., Choe J. Human papillomavirus E2 down-regulates the human telomerase reverse transcriptase promoter. J. Biol. Chem. 2002, 277:27748-27756.
140. Lee D., Lee B., Kim J., Kim D.W., Choe J. cAMP response element-binding protein-binding protein binds to human papillomavirus E2 protein and activates E2-dependent transcription. J. Biol. Chem. 2000, 275:7045-7051.
141. Lehman C.W., Botchan M.R. Segregation of viral plasmids depends on tethering to chromosomes and is regulated by phosphorylation. Proc. Nat. Acad. Sci. USA 1998, 95:4338-4343.
142. Lehman C.W., King D.S., Botchan M.R. A papillomavirus E2 phosphorylation mutant exhibits normal transient replication and transcription but is defective in transformation and plasmid retention. J. Virol. 1997, 71:3652-3665.
143. Leng X., Ludes-Meyers J.H., Wilson V.G. Isolation of an amino-terminal region of bovine papillomavirus type 1 E1 protein that retains origin binding and E2 interaction capacity. J. Virol. 1997, 71:848-852.
144. Leykauf K., Kabsch K., Gassler N., Gissmann L., Alonso A., Schenkel J. Expression of the HPV11 E2 gene in transgenic mice does not result in alterations of the phenotypic pattern. Transgenic Res. 2008, 17:1-8.
145. Li R., Botchan M.R. The acidic transcriptional activation domains of VP16 and p53 bind the cellular replication protein A and stimulate in vitro BPV-1 DNA replication. Cell 1993, 73:1207-1221.
146. Li R., Botchan M.R. Acidic transcription factors alleviate nucleosome-mediated repression of DNA replication of bovine papillomavirus type 1. Proc. Nat. Acad. Sci. USA 1994, 91:7051-7055.
147. Li R., Knight J., Bream G., Stenlund A., Botchan M. Specific recognition nucleotides and their DNA context determine the affinity of E2 protein for 17 binding sites in the BPV- 1 genome. Genes Dev. 1989, 3:510-526.
148. Lim D.A., Gossen M., Lehman C.W., Botchan M.R. Competition for DNA binding sites between the short and long forms of E2 dimers underlies repression in bovine papillomavirus type 1 DNA replication control. J. Virol. 1998, 72:1931-1940.
149. Maitland N.J., Conway S., Wilkinson N.S., Ramsdale J., Morris J.R., Sanders C.M., Burns J.E., Stern P.L., Wells M. Expression patterns of the human papillomavirus type 16 transcription factor E2 in low- and high-grade cervical intraepithelial neoplasia. J. Pathol. 1998, 186:275-280.
150. Massimi P., Pim D., Bertoli C., Bouvard V., Banks L. Interaction between the HPV-16 E2 transcriptional activator and p53. Oncogene 1999, 18:7748-7754.
151. Matsumoto T., Nakashima N., Takase K., Hirochika H., Mizuno H. A mutation study of the DNA binding domain of human papillomavirus type11 E2 protein. J. Biochem.(Tokyo) 1997, 121:138-144.
152. May M., Grassmann K., Pfister H., Fuchs P.G. Transcriptional silencer of the human papillomavirus type 8 late promoter interacts alternatively with the viral trans activator E2 or with a cellular factor. J. Virol. 1994, 68:3612-3619.
153. May M., Helbl V., Pfister H., Fuchs P.G. Unique topography of DNA-protein interactions in the non-coding region of epidermodysplasia verruciformis-associated human papillomaviruses. J. Gen. Virol. 1991, 72(Pt 12):2989-2997.
154. McBride A.A. Replication and partitioning of papillomavirus genomes. Adv. Virus Res. 2008, 72:155-205.
155. McBride A.A., Bolen J.B., Howley P.M. Phosphorylation sites of the E2 transcriptional regulatory proteins of bovine papillomavirus type 1. J. Virol. 1989, 63:5076-5085.
156. McBride A.A., Byrne J.C., Howley P.M. E2 polypeptides encoded by bovine papillomavirus type 1 form dimers through the common carboxyl-terminal domain: transactivation is mediated by the conserved amino-terminal domain. Proc. Nat. Acad. Sci. USA 1989, 86:510-514.
157. McBride A.A., Howley P.M. Bovine papillomavirus with a mutation in the E2 serine 301 phosphorylation site replicates at a high copy number. J. Virol. 1991, 65:6528-6534.
158. McBride A.A., Jang M.K. Current understanding of the role of the Brd4 protein in the Papillomavirus lifecycle. Viruses 2013, 5(6):1374-1394.
159. McBride A.A., Klausner R.D., Howley P.M. Conserved cysteine residue in the DNA-binding domain of the bovine papillomavirus type 1 E2 protein confers redox regulation of the DNA-binding activity in vitro. Proc. Nat. Acad. Sci. USA 1992, 89:7531-7535.
160. McBride A.A., Myers G. The E2 proteins: an update. Human Papillomaviruses 1997 1997, III54-III99. Los Alamos National Laboratory, Los Alamos. G. Myers, C. Baker, K. Munger, F. Sverdrup, A. McBride, H.U. Bernard (Eds.).
161. McBride A.A., Sakakibara N., Stepp W.H., Jang M.K. Hitchhiking on host chromatin: how papillomaviruses persist. Biochim. Biophys. Acta 2012, 1819:820-825.
162. McBride A.A., Schlegel R., Howley P.M. The carboxy-terminal domain shared by the bovine papillomavirus E2 transactivator and repressor proteins contains a specific DNA binding activity. EMBO J. 1988, 7:533-539.
163. McBride, A.A., van Doorslaer, K., 2013. (unpublished data).
164. McLaughlin-Drubin M., Munger K. The human papillomavirus type 8 E2 gene encodes a transforming activity sufficient for skin tumor formation in transgenic mice. J. Invest. Dermatol. 2008, 128:2142-2144.
165. McPhillips M.G., Oliveira J.G., Spindler J.E., Mitra R., McBride A.A. Brd4 is required for e2-mediated transcriptional activation but not genome partitioning of all papillomaviruses. J. Virol. 2006, 80:9530-9543.
166. McPhillips M.G., Ozato K., McBride A.A. Interaction of bovine papillomavirus E2 protein with Brd4 stabilizes its association with chromatin. J. Virol. 2005, 79:8920-8932.
167. McPhillips M.G., Veerapraditsin T., Cumming S.A., Karali D., Milligan S.G., Boner W., Morgan I.M., Graham S.V. SF2/ASF binds the human papillomavirus type 16 late RNA control element and is regulated during differentiation of virus-infected epithelial cells. J. Virol. 2004, 78:10598-10605.
168. Mohr I.J., Clark R., Sun S., Androphy E.J., MacPherson P., Botchan M.R. Targeting the E1 replication protein to the papillomavirus origin of replication by complex formation with the E2 transactivator. Science 1990, 250:1694-1699.
169. Mok Y.K., de Prat G.G., Butler P.J., Bycroft M. Equilibrium dissociation and unfolding of the dimeric human papillomavirus strain-16 E2 DNA-binding domain. Protein Sci. 1996, 5:310-319.
170. Mole S., Milligan S.G., Graham S.V. Human papillomavirus type 16 E2 protein transcriptionally activates the promoter of a key cellular splicing factor, SF2/ASF. J. Virol. 2009, 83:357-367.
171. Monini P., Blitz I.L., Cassai E. Cooperative DNA binding of the bovine papillomavirus E2 transcriptional activator is antagonized by truncated E2 polypeptides. J. Virol. 1993, 67:5668-5676.
172. Moody C.A., Laimins L.A. Human papillomaviruses activate the ATM DNA damage pathway for viral genome amplification upon differentiation. PLoS Pathog. 2009, 5:e1000605.
173. Moskaluk C., Bastia D. The E2 gene: of bovine papillomavirus encodes an enhancer-binding protein. Proc. Nat. Acad. Sci. USA 1987, 84:1215-1218.
174. Moskaluk C.A., Bastia D. Interaction of the bovine papillomavirus type 1 E2 transcriptional control protein with the viral enhancer: purification of the DNA-binding domain and analysis of its contact points with DNA. J. Virol. 1988, 62:1925-1931.
175. Moskaluk C.A., Bastia D. The bovine papillomavirus type 1 transcriptional activator E2 protein binds to its DNA recognition sequence as a dimer. Virology 1989, 169:236-238.
176. Muhlen S., Behren A., Iftner T., Simon C. Influence of HPV16 E2 and its localisation on the expression of matrix metalloproteinase-9. Int. J. Oncol. 2010, 37:337-345.
177. Muller M., Jacob Y., Jones L., Weiss A., Brino L., Chantier T., Lotteau V., Favre M., Demeret C. Large scale genotype comparison of human papillomavirus E2-host interaction networks provides new insights for e2 molecular functions. PLoS Pathog. 2012, 8:e1002761.
178. Muller A., Ritzkowsky A., Steger G. Cooperative activation of human papillomavirus type 8 gene expression by the E2 protein and the cellular coactivator p300. J. Virol. 2002, 76:11042-11053.
179. Muller F., Sapp M. Domains of the E1 protein of human papillomavirus type 33 involved in binding to the E2 protein. Virology 1996, 219:247-256.
180. Muller M., Demeret C. The HPV E2-host protein-protein interactions: a complex hijacking of the cellular network. Open Virol. J. 2012, 6:173-189.
181. Nadra A.D., Eliseo T., Mok Y.K., Almeida C.L., Bycroft M., Paci M., de Prat-Gay G., Cicero D.O Solution structure of the HPV-16 E2 DNA binding domain, a transcriptional regulator with a dimeric beta-barrel fold. J. Biomol. NMR 2004, 30:211-214.
182. Narechania A., Terai M., Burk R.D. Overlapping reading frames in closely related human papillomaviruses result in modular rates of selection within E2. J. Gen. Virol. 2005, 86:1307-1313.
183. Nishimura A., Ono T., Ishimoto A., Dowhanick J.J., Frizzell M.A., Howley P.M., Sakai H. Mechanisms of human papillomavirus E2-mediated repression of viral oncogene expression and cervical cancer cell growth inhibition. J. Virol. 2000, 74:3752-3760.
184. Okoye A., Cordano P., Taylor E.R., Morgan I.M., Everett R., Campo M.S. Human papillomavirus 16 L2 inhibits the transcriptional activation function, but not the DNA replication function, of HPV-16 E2. Virus Res. 2005, 108:1-14.
185. Oldak M., Maksym R.B., Sperling T., Yaniv M., Smola H., Pfister H.J., Malejczyk J., Smola S. Human papillomavirus type 8 E2 protein unravels JunB/Fra-1 as an activator of the beta4-integrin gene in human keratinocytes. J. Virol. 2010, 84:1376-1386.
186. Oldak M., Smola H., Aumailley M., Rivero F., Pfister H., Smola-Hess S. The human papillomavirus type 8 E2 protein suppresses beta4-integrin expression in primary human keratinocytes. J. Virol. 2004, 78:10738-10746.
187. Oliveira J.G., Colf L.A., McBride A.A. Variations in the association of papillomavirus E2 proteins with mitotic chromosomes. Proc. Nat. Acad. Sci. USA 2006, 103:1047-1052.
188. Ozbun M.A., Meyers C. Human papillomavirus type 31b E1 and E2 transcript expression correlates with vegetative viral genome amplification. Virology 1998, 248:218-230.
189. Parish J.L., Bean A.M., Park R.B., Androphy E.J. ChlR1 is required for loading papillomavirus E2 onto mitotic chromosomes and viral genome maintenance. Mol. Cell 2006, 24:867-876.
190. Peng Y.C., Breiding D.E., Sverdrup F., Richard J., Androphy E.J. AMF-1/Gps2 binds p300 and enhances its interaction with papillomavirus E2 proteins. J. Virol. 2000, 74:5872-5879.
191. Penrose K.J., Garcia-Alai M., Prat-Gay G., McBride A.A. CK2 phosphorylation-induced conformational switch triggers degradation of the papillomavirus E2 protein. J. Biol. Chem. 2004, 279:22430-22439.
192. Penrose K.J., McBride A.A. Proteasome-mediated degradation of the papillomavirus E2-TA protein is regulated by phosphorylation and can modulate viral genome copy number. J. Virol. 2000, 74:6031-6038.
193. Pepinsky R.B., Prakash S.S., Corina K., Grossel M.J., Barsoum J., Androphy E.J. Sequences flanking the core DNA-binding domain of bovine papillomavirus type 1 E2 contribute to DNA-binding function. J. Virol. 1997, 71:828-831.
194. Pfefferle R., Marcuzzi G.P., Akgul B., Kasper H.U., Schulze F., Haase I., Wickenhauser C., Pfister H. The human papillomavirus type 8 E2 protein induces skin tumors in transgenic mice. J. Invest. Dermatol. 2008, 128:2310-2315.
195. Phelps W.C., Howley P.M. Transcriptional trans-activation by the human papillomavirus type 16 E2 gene product. J. Virol. 1987, 61:1630-1638.
196. Piirsoo M., Ustav E., Mandel T., Stenlund A., Ustav M. Cis and trans requirements for stable episomal maintenance of the BPV-1 replicator. EMBO J. 1996, 15:1-11.
197. Poddar A., Reed S.C., McPhillips M.G., Spindler J.E., McBride A.A. The human papillomavirus type 8 E2 tethering protein targets the ribosomal DNA loci of host mitotic chromosomes. J. Virol. 2009, 83:640-650.
198. Powell M.L., Smith J.A., Sowa M.E., Harper J.W., Iftner T., Stubenrauch F., Howley P.M. NCoR1 mediates papillomavirus E8;E2C transcriptional repression. J. Virol. 2010, 84:4451-4460.
199. Prakash S.S., Grossman S.R., Pepinsky R.B., Laimins L.A., Androphy E.J. Amino acids necessary for DNA contact and dimerization imply novel motifs in the papillomavirus E2 transactivator. Genes Dev. 1992, 6:105-116.
200. Quinlan E.J., Culleton S.P., Wu S.Y., Chiang C.M., Androphy E.J. Acetylation of conserved lysines in bovine papillomavirus E2 by p300. J. Virol. 2013, 87:1497-1507.
201. Ramirez-Salazar E., Centeno F., Nieto K., Valencia-Hernandez A., Salcedo M., Garrido E. HPV16 E2 could act as down-regulator in cellular genes implicated in apoptosis, proliferation and cell differentiation. Virol. J. 2011, 8:247.
202. Rank N.M., Lambert P.F. Bovine papillomavirus type 1 E2 transcriptional regulators directly bind two cellular transcription factors, TFIID and TFIIB. J. Virol. 1995, 69:6323-6334.
203. Rehtanz M., Schmidt H.M., Warthorst U., Steger G. Direct interaction between nucleosome assembly protein 1 and the papillomavirus E2 proteins involved in activation of transcription. Mol. Cell. Biol. 2004, 24:2153-2168.
204. Reinson T., Toots M., Kadaja M., Pipitch R., Allik M., Ustav E., Ustav M. Engagement of the ATR-dependent dna damage response at the Human Papillomavirus 18 replication centers during the initial amplification. J. Virol. 2013, 87:951-964.
205. Riese D.J., Settleman J., Neary K., DiMaio D. Bovine papillomavirus E2 repressor mutant displays a high-copy- number phenotype and enhanced transforming activity. J. Virol. 1990, 64:944-949.
206. Rogers A., Waltke M., Angeletti P.C. Evolutionary variation of papillomavirus E2 protein and E2 binding sites. Virol. J. 2011, 8:379.
207. Romanczuk H., Thierry F., Howley P.M. Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P 97 and type 18 P 105 promoters. J. Virol. 1990, 64:2849-2859.
208. Sakai H., Yasugi T., Benson J.D., Dowhanick J.J., Howley P.M. Targeted mutagenesis of the human papillomavirus type 16 E2 transactivation domain reveals separable transcriptional activation and DNA replication functions. J. Virol. 1996, 70:1602-1611.
209. Sakakibara, N., Chen, D., Jang, M.K., McBride, A.A., 2013. The Brd4 chromatin adaptor protein is displaced from nuclear foci as the HPV E2 protein switches from transcriptional to replicational modes. (manuscript in submission).
210. Sakakibara N., Chen D., McBride A.A. Papillomaviruses use recombination dependent replication to vegetatively amplify their genomes in differentiated cells. PLOS Pathogens 2013, http://dx.doi.org/10.1371/journal.ppat.1003321 (in press).
211. Sakakibara N., Mitra R., McBride A.A. The papillomavirus E1 helicase activates a cellular DNA damage response in viral replication foci. J. Virol. 2011, 85:8981-8995.
212. Sanchez I.E., Dellarole M., Gaston K., Gay G.D. Comprehensive comparison of the interaction of the E2 master regulator with its cognate target DNA sites in 73 human papillomavirus types by sequence statistics. Nucl. Acids Res. 2007.
213. Sanders C.M., Sizov D., Seavers P.R., Ortiz-Lombardia M., Antson A.A. Transcription activator structure reveals redox control of a replication initiation reaction. Nucl. Acids Res. 2007, 35:3504-3515.
214. Sanders C.M., Stenlund A. Recruitment and loading of the E1 initiator protein: an ATP-dependent process catalysed by a transcription factor. EMBO J. 1998, 17:7044-7055.
215. Sanders C.M., Stenlund A. Transcription factor-dependent loading of the E1 initiator reveals modular assembly of the papillomavirus origin melting complex. J. Biol. Chem. 2000, 275:3522-3534.
216. Sanders C.M., Stenlund A. Mechanism and requirements for bovine papillomavirus, type 1, E1 initiator complex assembly promoted by the E2 transcription factor bound to distal sites. J. Biol. Chem. 2001, 276:23689-23699.
217. Sanders C.M., Stern P.L., Maitland N.J. Characterization of human papillomavirus type 16 E2 protein and subdomains expressed in insect cells. Virology 1995, 211:418-433.
218. Sarafi T.R., McBride A.A. Domains of the BPV-1 E1 replication protein required for origin-specific DNA binding and interaction with the E2 transactivator. Virology 1995, 211:385-396.
219. Schmidt H.M., Steger G., Pfister H. Competitive binding of viral E2 protein and mammalian core-binding factor to transcriptional control sequences of human papillomavirus type 8 and bovine papillomavirus type 1. J. Virol. 1997, 71:8029-8034.
220. Schuck S., Stenlund A. Assembly of a double hexameric helicase. Mol. Cell 2005, 20:377-389.
221. Schuck S., Stenlund A. Surface mutagenesis of the bovine papillomavirus E1 DNA binding domain reveals residues required for multiple functions related to DNA replication. J. Virol. 2006, 80:7491-7499.
222. Schwarz E., Freese U.K., Gissmann L., Mayer W., Roggenbuck B., Stremlau A., zur Hausen H. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 1985, 314:111-114.
223. Schweiger M.R., Ottinger M., You J., Howley P.M. Brd4 independent transcriptional repression function of the papillomavirus E2 proteins. J. Virol. 2007, 81:9612-9622.
224. Schweiger M.R., You J., Howley P.M. Bromodomain protein 4 mediates the papillomavirus e2 transcriptional activation function. J. Virol. 2006, 80:4276-4285.
225. Sedman J., Stenlund A. The papillomavirus E1 protein forms a DNA-dependent hexameric complex with ATPase and DNA helicase activities. J. Virol. 1998, 72:6893-6897.
226. Sekhar V., McBride A.A. Phosphorylation regulates binding of the human papillomavirus type 8 E2 protein to host chromosomes. J. Virol. 2012, 86:10047-10058.
227. Sekhar V., Reed S.C., McBride A.A. Interaction of the betapapillomavirus E2 tethering protein with mitotic chromosomes. J. Virol. 2010, 84:543-557.
228. Sekine H., Fuse A., Inaba N., Takamizawa H., Simizu B. Detection of the human papillomavirus 6b E2 gene product in genital condyloma and laryngeal papilloma tissues. Virology 1989, 170:92-98.
229. Senechal H., Poirier G.G., Coulombe B., Laimins L.A., Archambault J. Amino acid substitutions that specifically impair the transcriptional activity of papillomavirus E2 affect binding to the long isoform of Brd4. Virology 2007, 358:10-17.
230. Sim J., Ozgur S., Lin B.Y., Yu J.H., Broker T.R., Chow L.T., Griffith J. Remodeling of the human papillomavirus type 11 replication origin into discrete nucleoprotein particles and looped structures by the E2 protein. J. Mol. Biol. 2008, 375:1165-1177.
231. Skiadopoulos M.H., McBride A.A. The BPV-1 E2 transactivator and E2-TR repressor use different nuclear localization signals. J. Virol. 1996, 70:1117-1124.
232. Skiadopoulos M.H., McBride A.A. Bovine papillomavirus type 1 genomes and the E2 transactivator protein are closely associated with mitotic chromatin. J. Virol. 1998, 72:2079-2088.
233. Smal C., Wetzler D.E., Dantur K.I., Chemes L.B., Garcia-Alai M.M., Dellarole M., Alonso L.G., Gaston K., de Prat-Gay G. The human papillomavirus E7-E2 interaction mechanism in vitro reveals a finely tuned system for modulating available E7 and E2 proteins. Biochemistry 2009, 48:11939-11949.
234. Smith D.I., Zhu Y., McAvoy S., Kuhn R. Common fragile sites, extremely large genes, neural development and cancer. Cancer Lett. 2006, 232:48-57.
235. Smith J.A., White E.A., Sowa M.E., Powell M.L., Ottinger M., Harper J.W., Howley P.M. Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression. Proc. Nat. Acad. Sci. USA 2010, 107:3752-3757.
236. Spalholz B.A., Vande Pol S.B., Howley P.M. Characterization of the cis elements involved in basal and E2-transactivated expression of the bovine papillomavirus P 2443 promoter. J. Virol. 1991, 65:743-753.
237. Spalholz B.A., Yang Y.C., Howley P.M. Transactivation of a bovine papilloma virus transcriptional regulatory element by the E2 gene product. Cell 1985, 42:183-191.
238. Steger G., Corbach S. Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein. J. Virol. 1997, 71:50-58.
239. Steger G., Schnabel C., Schmidt H.M. The hinge region of the human papillomavirus type 8 E2 protein activates the human p21(WAF1/CIP1) promoter via interaction with Sp1. J. Gen. Virol. 2002, 83:503-510.
240. Stenlund A. E1 initiator DNA binding specificity is unmasked by selective inhibition of non-specific DNA binding. EMBO J. 2003, 22:954-963.
241. Stenlund A., Botchan M.R. The E2 trans -activator can act as a repressor by interfering with a cellular transcription factor. Genes Dev. 1990, 4:123-136.
242. Strasswimmer J., Lorson C.L., Breiding D.E., Chen J.J., Le T., Burghes A.H., Androphy E.J. Identification of survival motor neuron as a transcriptional activator-binding protein. Hum. Mol. Genet. 1999, 8:1219-1226.
243. Stubenrauch F., Colbert A.M., Laimins L.A. Transactivation by the E2 protein of oncogenic human papillomavirus type 31 is not essential for early and late viral functions. J. Virol. 1998, 72:8115-8123.
244. Stubenrauch F., Hummel M., Iftner T., Laimins L.A. The E8E2C protein, a negative regulator of viral transcription and replication, is required for extrachromosomal maintenance of human papillomavirus type 31 in keratinocytes. J. Virol. 2000, 74:1178-1186.
245. Stubenrauch F., Leigh I.M., Pfister H. E2 represses the late gene promoter of human papillomavirus type 8 at high concentrations by interfering with cellular factors. J. Virol. 1996, 70:119-126.
246. Stubenrauch F., Lim H.B., Laimins L.A. Differential requirements for conserved E2 binding sites in the life cycle of oncogenic human papillomavirus type 31. J. Virol. 1998, 72:1071-1077.
247. Stubenrauch F., Pfister H. Low-affinity E2-binding site mediates downmodulation of E2 transactivation of the human papillomavirus type 8 late promoter. J. Virol. 1994, 68:6959-6966.
248. Stubenrauch F., Straub E., Fertey J., Iftner T. The E8 repression domain can replace the E2 transactivation domain for growth inhibition of HeLa cells by papillomavirus E2 proteins. Int. J. Cancer 2007, 121:2284-2292.
249. Stubenrauch F., Zobel T., Iftner T. The E8 domain confers a novel long-distance transcriptional repression activity on the E8E2C protein of high-risk human papillomavirus type 31. J. Virol. 2001, 75:4139-4149.
250. Swindle C.S., Zou N., Van Tine B.A., Shaw G.M., Engler J.A., Chow L.T. Human papillomavirus DNA replication compartments in a transient DNA replication system. J. Virol. 1999, 73:1001-1009.
251. ∧E4 chimera: 2 new spliced transcripts and proteins induced by keratinocyte differentiation. Virology 2012, 429:47-56.
252. Tan S.H., Leong L.E., Walker P.A., Bernard H.U. The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID. J. Virol. 1994, 68:6411-6420.
253. Taylor E.R., Boner W., Dornan E.S., Corr E.M., Morgan I.M. UVB irradiation reduces the half-life and transactivation potential of the human papillomavirus 16 E2 protein. Oncogene 2003, 22:4469-4477.
254. Thain A., Jenkins O., Clarke A.R., Gaston K. CpG methylation directly inhibits binding of the human papillomavirus type 16 E2 protein to specific DNA sequences. J. Virol. 1996, 70:7233-7235.
255. Thierry F., Demeret C. Direct activation of caspase 8 by the proapoptotic E2 protein of HPV18 independent of adaptor proteins. Cell Death Differ. 2008, 15:1356-1363.
256. Thierry F., Howley P.M. Functional analysis of E2-mediated repression of the HPV18 P105 promoter. New Biol. 1991, 3:90-100.
257. Thierry F., Yaniv M. The BPV1-E2 trans-acting protein can be either an activator or a repressor of the HPV18 regulatory region. EMBO J. 1987, 6:3391-3397.
258. Titolo S., Pelletier A., Pulichino A.M., Brault K., Wardrop E., White P.W., Cordingley M.G., Archambault J. Identification of domains of the human papillomavirus type 11 E1 helicase involved in oligomerization and binding to the viral origin. J. Virol. 2000, 74:7349-7361.
259. Turan T., Kalantari M., Calleja-Macias I.E., Cubie H.A., Cuschieri K., Villa L.L., Skomedal H., Barrera-Saldana H.A., Bernard H.U. Methylation of the human papillomavirus-18 L1 gene: a biomarker of neoplastic progression?. Virology 2006, 349:175-183.
260. Ustav E., Ustav M., Szymanski P., Stenlund A. The bovine papillomavirus origin of replication requires a binding site for the E2 transcriptional activator. Proc. Nat. Acad. Sci. USA 1993, 90:898-902.
261. Ustav M., Ustav E., Szymanski P., Stenlund A. Identification of the origin of replication of bovine papillomavirus and characterization of the viral origin recognition factor E1. EMBO J. 1991, 10:4321-4329.
262. Vaillancourt P., Nottoli T., Choe J., Botchan M.R. The E2 transactivator of bovine papillomavirus type 1 is expressed from multiple promoters. J. Virol. 1990, 64:3927-3937.
263. van Doorslaer, K., Khan, J., Chapman, S., McBride, A.A., 2013. Three E2 binding sites are sufficient for stable episomal maintenance of HPV18. (manuscript in preparation).
264. Van Tine B.A., Dao L.D., Wu S.Y., Sonbuchner T.M., Lin B.Y., Zou N., Chiang C.M., Broker T.R., Chow L.T. Human papillomavirus (HPV) origin-binding protein associates with mitotic spindles to enable viral DNA partitioning. Proc. Natl. Acad. Sci. USA 2004, 101:4030-4035.
265. Vande Pol S.B., Howley P.M. A bovine papillomavirus constitutive enhancer is negatively regulated by the E2 repressor through competitive binding for a cellular factor. J. Virol. 1990, 64:5420-5429.
266. Veeraraghavan S., Mello C.C., Lee K.M., Androphy E.J., Baleja J.D. 1H, 15N, and 13C NMR resonance assignments for the DNA-binding domain of the BPV-1 E2 protein. J. Biomol. NMR 1998, 11:457-458.
267. Vempati R.K. DNA damage in the presence of chemical genotoxic agents induce acetylation of H3K56 and H4K16 but not H3K9 in mammalian cells. Mol. Biol. Rep. 2012, 39:303-308.
268. Vosa L., Sudakov A., Remm M., Ustav M., Kurg R. Identification and analysis of papillomavirus E2 protein binding sites in the human genome. J. Virol. 2012, 86:348-357.
269. Wang X., Helfer C.M., Pancholi N., Bradner J.E., You J. Recruitment of brd4 to the human papillomavirus type 16 DNA replication complex is essential for replication of viral DNA. J. Virol. 2013, 87:3871-3884.
270. Wang X., Naidu S.R., Sverdrup F., Androphy E.J. Tax1BP1 interacts with papillomavirus E2 and regulates E2-dependent transcription and stability. J. Virol. 2009, 83:2274-2284.
271. Wang Y., Coulombe R., Cameron D.R., Thauvette L., Massariol M.J., Amon L.M., Fink D., Titolo S., Welchner E., Yoakim C., Archambault J., White P.W. Crystal structure of the E2 transactivation domain of human papillomavirus type 11 bound to a protein interaction inhibitor. J. Biol. Chem. 2004, 279:6976-6985.
272. Wang W., Fang Y., Sima N., Li Y., Li W., Li L., Han L., Liao S., Han Z., Gao Q., Li K., Deng D., Meng L., Zhou J., Wang S., Ma D. Triggering of death receptor apoptotic signaling by human papillomavirus 16 E2 protein in cervical cancer cell lines is mediated by interaction with c-FLIP. Apoptosis 2011, 16:55-66.
273. Webster K., Parish J., Pandya M., Stern P.L., Clarke A.R., Gaston K. The human papillomavirus (HPV) 16 E2 protein induces apoptosis in the absence of other HPV proteins and via a p53-dependent pathway. J. Biol. Chem. 2000, 275:87-94.
274. Winokur P.L., McBride A.A. Separation of the transcriptional activation and replication functions of the bovine papillomavirus-1 E2 protein. EMBO J. 1992, 11:4111-4118.
275. Winokur P.L., McBride A.A. The transactivation and DNA binding domains of the BPV-1 E2 protein have different roles in cooperative origin binding with the E1 protein. Virology 1996, 221:44-53.
276. Wu S.Y., Lee A.Y., Hou S.Y., Kemper J.K., Erdjument-Bromage H., Tempst P., Chiang C.M. Brd4 links chromatin targeting to HPV transcriptional silencing. Genes Dev. 2006, 20:2383-2396.
277. Wu M.H., Chan J.Y., Liu P.Y., Liu S.T., Huang S.M. Human papillomavirus E2 protein associates with nuclear receptors to stimulate nuclear receptor- and E2-dependent transcriptional activations in human cervical carcinoma cells. Int. J. Biochem. Cell Biol. 2007, 39:413-425.
278. Wu M.H., Huang C.J., Liu S.T., Liu P.Y., Ho C.L., Huang S.M. Physical and functional interactions of human papillomavirus E2 protein with nuclear receptor coactivators. Biochem. Biophys. Res. Commun. 2007, 356:523-528.
279. Wu Y.C., Bian X.L., Heaton P.R., Deyrieux A.F., Wilson V.G. Host cell sumoylation level influences papillomavirus E2 protein stability. Virology 2009, 387:176-183.
280. Wu Y.C., Roark A.A., Bian X.L., Wilson V.G. Modification of papillomavirus E2 proteins by the small ubiquitin-like modifier family members (SUMOs). Virology 2008, 378:329-338.
281. Xue Y., Bellanger S., Zhang W., Lim D., Low J., Lunny D., Thierry F. HPV16 E2 is an immediate early marker of viral infection, preceding E7 expression in precursor structures of cervical carcinoma. Cancer Res. 2010, 70:5316-5325.
282. Yao J.M., Breiding D.E., Androphy E.J. Functional interaction of the bovine papillomavirus E2 transactivation domain with TFIIB. J. Virol. 1998, 72:1013-1019.
283. Yasugi T., Benson J.D., Sakai H., Vidal M., Howley P.M. Mapping and characterization of the interaction domains of human papillomavirus type 16 E1 and E2 proteins. J. Virol. 1997, 71:891-899.
284. You J., Croyle J.L., Nishimura A., Ozato K., Howley P.M. Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes. Cell 2004, 117:349-360.
285. You J., Schweiger M.R., Howley P.M. Inhibition of E2 binding to Brd4 enhances viral genome loss and phenotypic reversion of bovine papillomavirus-transformed cells. J. Virol. 2005, 79:14956-14961.
286. Yu T., Peng Y.C., Androphy E.J. Mitotic kinesin-like protein 2 binds and colocalizes with papillomavirus E2 during mitosis. J. Virol. 2007, 81:1736-1745.
287. Zhao K.N., Hengst K., Liu W.J., Liu Y.H., Liu X.S., McMillan N.A., Frazer I.H. BPV1 E2 protein enhances packaging of full-length plasmid DNA in BPV1 pseudovirions. Virology 2000, 272:382-393.
288. Zheng G., Schweiger M.R., Martinez-Noel G., Zheng L., Smith J.A., Harper J.W., Howley P.M. Brd4 regulation of papillomavirus protein E2 stability. J. Virol. 2009, 83:8683-8692.
289. Zheng P.S., Brokaw J., McBride A.A. Conditional mutations in the mitotic chromosome binding function of the bovine papillomavirus type 1 E2 protein. J. Virol. 2005, 79:1500-1509.
290. Zobel T., Iftner T., Stubenrauch F. The papillomavirus E8-E2C protein represses DNA replication from extrachromosomal origins. Mol. Cell. Biol. 2003, 23:8352-8362.
291. Zou N., Lin B.Y., Duan F., Lee K.Y., Jin G., Guan R., Yao G., Lefkowitz E.J., Broker T.R., Chow L.T. The hinge of the human papillomavirus type 11 E2 protein contains major determinants for nuclear localization and nuclear matrix association. J. Virol. 2000, 74:3761-3770.